5/14
08:15 am
cadl
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
5/14
08:00 am
cadl
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Medium
Report
Candel Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
4/25
08:10 am
cadl
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting [Yahoo! Finance]
Medium
Report
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting [Yahoo! Finance]
4/25
08:00 am
cadl
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
Medium
Report
Candel Therapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting
4/12
12:07 pm
cadl
Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag [Yahoo! Finance]
Medium
Report
Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag [Yahoo! Finance]
4/11
05:04 pm
cadl
GLYC, APLD and AUTL are among after hour movers [Seeking Alpha]
Medium
Report
GLYC, APLD and AUTL are among after hour movers [Seeking Alpha]
4/11
01:03 pm
cadl
NKTR, VERU and EGIO among mid-day movers [Seeking Alpha]
Low
Report
NKTR, VERU and EGIO among mid-day movers [Seeking Alpha]
4/11
09:07 am
cadl
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer [Yahoo! Finance]
High
Report
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer [Yahoo! Finance]
4/11
09:00 am
cadl
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
High
Report
Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
4/9
08:13 am
cadl
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors [Yahoo! Finance]
High
Report
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors [Yahoo! Finance]
4/9
08:00 am
cadl
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
High
Report
Candel Therapeutics Presents Preclinical Data at AACR on Immunotherapy Candidate for Induction of Tertiary Lymphoid Structures in Solid Tumors
4/6
10:20 am
cadl
Retail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewarded [Yahoo! Finance]
Low
Report
Retail investors invested in Candel Therapeutics, Inc. (NASDAQ:CADL) up 320% last week, insiders too were rewarded [Yahoo! Finance]
4/5
01:52 pm
cadl
Candel (CADL) Up on Upbeat Data From Pancreatic Cancer Study [Yahoo! Finance]
High
Report
Candel (CADL) Up on Upbeat Data From Pancreatic Cancer Study [Yahoo! Finance]
4/5
11:12 am
cadl
CNN values your feedback [CNN]
High
Report
CNN values your feedback [CNN]
4/4
12:39 pm
cadl
After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study [Yahoo! Finance]
High
Report
After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study [Yahoo! Finance]
4/4
08:10 am
cadl
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer [Yahoo! Finance]
Neutral
Report
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer [Yahoo! Finance]
4/4
08:00 am
cadl
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
High
Report
Candel Therapeutics Announces Positive Interim Data from Randomized Phase 2 Clinical Trial of CAN-2409 in Non-Metastatic Pancreatic Cancer
3/28
04:10 pm
cadl
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma [Yahoo! Finance]
High
Report
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma [Yahoo! Finance]
3/28
04:05 pm
cadl
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
High
Report
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
3/28
08:17 am
cadl
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
Medium
Report
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights [Yahoo! Finance]
3/28
08:05 am
cadl
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
Low
Report
Candel Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Highlights
3/27
10:21 am
cadl
SecondWave Systems Announces Professor Paul Peter Tak as New Advisory Board Member and Secures $3M Additional Financing to Accelerate Development of Novel Ultrasound-Based Anti-Inflammatory Therapy [Yahoo! Finance]
Medium
Report
SecondWave Systems Announces Professor Paul Peter Tak as New Advisory Board Member and Secures $3M Additional Financing to Accelerate Development of Novel Ultrasound-Based Anti-Inflammatory Therapy [Yahoo! Finance]
3/5
04:43 pm
cadl
Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate [Yahoo! Finance]
Medium
Report
Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate [Yahoo! Finance]
3/5
04:30 pm
cadl
Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate
Medium
Report
Candel Therapeutics Announces an Upcoming Presentation at the AACR Annual Meeting Unveiling New Cancer Immunotherapy Candidate
2/27
07:12 am
cadl
American Brain Tumor Association Announces New Board of Directors Officers and Members [Yahoo! Finance]
Medium
Report
American Brain Tumor Association Announces New Board of Directors Officers and Members [Yahoo! Finance]